Ranbaxy is the subject of a Class 2
Drug Alert by the UK Medicines
and Healthcare products
Regulatory Agency over the product
information included in batches of
its Mirtazapine 15mg tablets.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 14 May 10 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 May 10
THE Pharmacy Guild of Australia has released new CPD-accredited online training modules for community pharmacies conducting interventions with eligible patients as part of the 6CPA-funded Chronic Pain MedsCheck Trial.